Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis

Slides: 1–12 of 37
Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients
With Cystic Fibrosis Prepared for: Agency for Healthcare Research and Quality (AHRQ) (www.ahrq.gov)

Effectiveness of Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis

Outline of Material

Health Impact of Cystic Fibrosis in the United States

Characteristics of CF: Origin of the Disease

Rationale for Use of Recombinant Human Growth Hormone (rhGH) in Patients With CF

Approved Therapeutic Uses of rhGH

Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review (CER) Development

Clinical Questions Addressed by the CER (2)

Rating the Strength of Evidence From the CER: A Modification of the GRADE Methodology

Pages: [1] 2 3 4 Next